Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0CJ7Z
|
|||
| Drug Name |
Abicipar pegol
|
|||
| Indication | Diabetic macular edema [ICD-11: 9B71.02] | Phase 2 | [1] | |
| Company |
Allergan Parsippany, NJ Molecular Partners Zurich, Switzerland
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.